Member Info for PrivateRyan

I see there are three antibiotics mentioned in that comprehensive article other than vancomycin. Will Iclaprim blow them away? Or are they real competitors ?

Didn’t happen with the phase 3 trials ? Why this time?

?

it's the calm because there is nothing new to say!we need more of that....less hot air etc etc

BUT AVX quarterly results due out in a couple of hours ,though there isnt that usually much detail on individual product performance therein if I recall.

Luxturna (voretigene neparvovec)
Inherited retinal dystrophies
Approved 12/19/2017
PDUFA date January 12, 2018 under priority review. Approval announced December 19, 2017.

So it can happen.......fingers crossed No more from me now until joy or despair strikes!

Tezacaftor (VX-661) / ivacaftor
Cystic fibrosis - Two Copies of the F508del Mutation
Approved 02/12/2018
Phttps://www.biopharmcatalyst.com/calendars/historical-catalyst-calendarDUFA date under priority review February 28, 2017. Approval announced February 12, 2018.
I have a good feeling about this - so much history re iclaprim and such a good set of results for a novel a b

The nicety I might have missed! Hey ho. I am in for the kill ! Thanks for all the input over the years ivy and others

Sorry I thought I had found a precedent? Accept I don’t understand all the niceties but it was a 6 month priority approved after 5 months I thought? Anyway we are so close now who cares. I am gonna run the full gauntlet up to 13 th having got the mrs approval to stay fully invested and that is no mean feat given her Yorkshire background !! I hope we are right ......

NVS Kymriah (CTL019)
Relapsed/Refractory B-Cell Acute lymphoblastic leukemia
Approved 08/30/2017
PDUFA date under priority review announced March 29, 2017. Approval announced early - August 30, 2017.
https://www.biopharmcatalyst.com/calendars/historical-catalyst-calendar
for a priority approval drug
but I agree its unusual

thanks ian b - says approval should be a "breeze"-hope he is right.For balance I think it was recorded on october 9th ,but as we know nothing has happened in the meantime to change he analysis ,except the fact the FDA did not seek any further info to continue with their review- another good sign.

squeaky bum time coming up though- a slim risk of failure is still a risk....hope I can hold firm -I have a lot to lose but equally an awful lot to gain ....

Not so. Jack bogle rip set up index trackers in vanguard a long long time ago ....a nd that is why index trackers are taking funds away from active managers now and have been for years . warren buffet agreed Look at Woodford fund.... the great guru has had a bad few years now But I hold and will do so despite the ramping ...until we get good or bad news. Can’t people just be patient. And it is illegal to insider deal btw. O s is right on that. But videos like kongats used to do do provide vibes......as do presentations Be patient my friends

iis are not gods- they often make mistakes and most fund managers do not beat the index from year to year .So no great comfort in my view ,but I agree it is much better than their selling from the s p perspective!

This share will be dead in the water without a motor until real news arrives...............kites and straws and techie blurb will not work ....keep calm and carry on

o s the cases are not going to be heard till mid next year from memory .i havent access o the legal documentation to be able to understand the counterclaim.

project fear from the naughty boy at the back of the class-no evidence -not worth further comment

a 2015 report.......the proof of the pudding will be in the eating.......this share is becalmed until we get substantive new news....

Continuous?!!are you kidding?

Thanks parkez! Hope we get an auto deal ....actually any deal!soon. Cheers

Not so quietly lol

We don’t seem to be mentioned in the list of companies mentioned? Maybe not so promising?

omg ps is back -hoped he had gone the way of welsh vagabond- rampers and kites back in force today lol!